Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?
Ramachandran
S
S
Department of Clinical Biochemistry, North Staffordshire Hospital, Stoke on Trent ST4 7PA.
French
J M
JM
Vanderpump
M P
MP
Croft
P
P
Neary
R H
RH
D000368:Aged; D003327:Coronary Disease / Q000517:prevention & control*; D016208:Databases, Factual; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012016:Reference Values; D018570:Risk Assessment / Q000379:methods
D000960:Hypolipidemic Agents